2020-12-25,Acasti (ACST) Moves to Buy: Rationale Behind the Upgrade
2020-12-23,Acasti Pharma Unaware of Any Material Change
2020-11-16,Acasti Pharma Provides Business Update for the Second Quarter of Fiscal 2021
2020-11-12,Here's Why Acasti Pharma (CVE:ACST) Must Use Its Cash Wisely
2020-10-01,"Acasti Pharma Announces the Election of Its Directors, Advisory Resolution Approving Compensation, Amendments to Its Stock Option and Equity Incentive Plans, Adoption of Amended & Restated General By-Law and Other Related Matters Approved at Its AGM"
2020-09-29,Acasti Announces Review Process of Strategic Alternatives
2020-09-16,Acasti Appoints Seasoned Executive Brian D. Ford CPA-CA as Chief Financial Officer
2020-09-11,Acasti Announces Filing and Mailing of Information Circular and Change in Record Date
2020-09-01,Acasti Pharma Stock Loses a Wall Street Supporter
2020-08-31,Acasti Pharma Reports Topline Triglyceride Results from Phase 3 TRILOGY 2 Study of CaPre in Patients with Severe Hypertriglyceridemia
2020-08-14,What Makes Acasti (ACST) a New Buy Stock
2020-08-13,Acasti Pharma Provides Business Update for the First Quarter of Fiscal 2021
2020-07-31,"Acasti Pharma Submits Statistical Analysis Plan to FDA and Remains On Track to Report TRILOGY 2 Topline Data On or About August 31, 2020"
2020-07-06,Why Acasti Pharma's Stock Is Trading Higher Today
2020-06-29,Acasti Pharma Provides Fiscal 2020 Year-End Business Update
2020-06-19,Acasti Pharma Receives FDA Response to TRILOGY 1 Briefing Package
2020-06-04,Hedge Funds Souring On Acasti Pharma Inc. (ACST)
2020-05-06,Does The Acasti Pharma Inc. (CVE:ACST) Share Price Fall With The Market?
2020-04-30,Acasti Pharma Announces Submission of TRILOGY 1 Briefing Package to FDA
2020-04-20,Acasti Pharma Awarded Notice of Allowance for Second Composition of Matter Patent in Canada
2020-04-01,"Acasti Pharma Submits FDA Meeting Request on Schedule, and FDA Meeting Expected in the Second Half of June"
2020-03-11,Acasti Pharma Awarded Notice of Allowance for Additional Composition of Matter and Method of Use Patents in the United States and Mexico
2020-03-06,Amarin Stock Looks Like a Heart-Healthy Buy on the Dip
2020-02-28,Acasti Receives NASDAQ Notification Regarding Minimum Bid Requirements
2020-02-28,Look Anywhere but Acasti Pharma Stock for Opportunity
2020-02-28,Confounding Decline Creates an Opportunity in Amarin Stock
2020-02-14,"Risks Remain, but Amarin Stock Is a Buy at Todays Prices"
2020-02-14,Acasti Pharma Provides Business Update for the Third Quarter of Fiscal 2020
2020-02-13,Acasti Pharma Schedules Third Quarter Fiscal 2020 and Business Update Conference Call
2020-02-11,3 Beaten-Down Biotech Stocks With +50% Upside Potential
2020-02-11,"The Daily Biotech Pulse: LogicBio Slapped With Clinical Hold, Agile Inks Debt Deal Ahead of Twirla Approval, Gilead Builds Stake In Sierra Oncology"
2020-02-10,Acasti Pharma Provides Update on TRILOGY 1 and TRILOGY 2 Phase 3 Trials of CaPre
2020-01-17,Does Acasti Stock Have a Future?
2020-01-17,Why Amarin Stock Is Poised for a Healthy 2020
2020-01-14,AstraZeneca to End Phase III Study on Fish Oil Heart Drug
2020-01-14,"The Daily Biotech Pulse: PhaseBio To Buy Hypertension Asset, Stemline Falls On Q4 Pre-Announcement, FDA Panel To Review Nektar's Opioid Drug"
2020-01-13,This Biotech Stock Is Flying High After Rival Heart Drugs Stumbled
2020-01-13,"Amarin's stock surges, as rival drugs from AstraZeneca, Acasti disappoint"
2020-01-13,Neptune Provides Updates on Non-Core Investments
2020-01-13,Amarin Stock Is Surging as Rival Makers of Fish-Oil Heart Drugs Fall Short
2020-01-13,This Biotech Stock Is Flying High After Rival Heart Drugs Stumbled
2020-01-13,Acasti Pharma Reports Topline Results for TRILOGY 1 Phase 3 Trial of CaPre
2020-01-10,All Bets Are Off for Amarin Stock
2020-01-09,3 Healthcare Stocks With Big Catalysts in January
2019-12-24,Acasti Delays Data Readout For Drug To Treat Elevated Triglycerides
2019-12-24,"Benzinga Pro's Top 5 Stocks To Watch For Tues., Dec. 24, 2019: TSLA, WCC, ACST, YMAB, ITCI"
2019-12-24,"The Daily Biotech Pulse: NewLink Genetics Licenses Ovarian Cancer Dug, Correvio Awaits FDA Verdict"
2019-12-23,Acasti Pharma Provides Update on Timing of Topline Results for TRILOGY 1 Phase 3 Trial of CaPre
2019-12-22,Hedge Funds Have Never Been This Bullish On Acasti Pharma Inc. (ACST)
2019-12-20,Amarin Stock is at Sky-High Levels Already Assumes All the Good News
2019-11-26,Acasti Pharma Reports Last Patient Visit in TRILOGY 1 Phase 3 Trial of CaPre for the Treatment of Severe Hypertriglyceridemia
2019-11-25,"Encode Ideas, L.P. Announces the Initiation of Research Coverage on Acasti Pharma, Inc."
2019-11-21,Amarin's Shares Down on Underperform Rating by Oppenheimer
2019-11-18,"Acasti Pharma Releases Preliminary New Animal Data, and Gains Insights Into CaPres Novel Mechanism of Action in Diabetes"
2019-11-13,Acasti Pharma Provides Business Update for the Second Quarter of Fiscal 2020
2019-11-07,Acasti Pharma Announces Publication of CaPre Pharmacokinetics Study in a Leading Peer-Reviewed Journal
2019-11-06,Acasti Pharma Schedules Second Quarter Fiscal 2020 Conference Call
2019-11-04,Acasti Pharma Partners with Aker BioMarine to Supply Krill Oil for CaPre®
2019-10-01,Acasti Pharma to Present at the 2019 Cantor Fitzgerald Global Healthcare Conference
2019-09-30,"Acasti Pharma Announces Additional Phase 3 Milestones Reached, and Remains on Track to Report Topline Results for TRILOGY 1 in December 2019 and TRILOGY 2 in January 2020"
2019-09-27,Do Insiders Own Lots Of Shares In Acasti Pharma Inc. (CVE:ACST)?
2019-09-09,Acasti Pharma Receives Funding from the Government of Canada to Expand Production Capacity
2019-09-04,Acasti Pharma to Present at the 21st Annual Rodman & Renshaw Global Investment Conference in New York City on September 9th
2019-08-28,"Acasti Pharma Announces the Election of Its Directors, Amendments to Its Stock Option and Equity Incentive Plans and Other Related Matters Approved at Its AGM"
2019-08-14,Acasti Pharma Provides Business Update for the First Quarter of Fiscal 2020
2019-08-09,"Acasti Pharma Co-Founder, Chief Operating and Scientific Officer to Participate on Lipid Panel at the 2019 BTIG Biotechnology Conference"
2019-08-07,Acasti Pharma Schedules First Quarter Fiscal 2020 Conference Call
2019-07-25,Acasti Pharma Comments on Trading Activity and Reaffirms No Plans to Raise Capital
2019-07-05,Bausch Gains 38.9% YTD on Product Launches &amp; Debt Reduction
2019-06-26,Acasti Pharma Trades Higher Despite 'Material Uncertainty'
2019-06-26,"Acasti Pharma, Inc. to Host Earnings Call"
2019-06-26,Acasti Pharma Provides Fiscal 2019 Year-End Business Update
2019-06-24,Acasti Pharma Awarded Notice of Allowance for a Second Patent in China Covering CaPres Omega-3 Phospholipid Composition
2019-06-19,Acasti Pharma Schedules Fourth Quarter and Fiscal 2019 Conference Call
2019-06-04,Acasti Pharma Announces TRILOGY 2 Trial Has Achieved its 100% Patient Randomization Target in Patients with Severe Hypertriglyceridemia
2019-05-23,Acasti Issues Shares in Settlement of Claims with Former Chief Executive Officer
2019-05-21,Acasti Pharma to Present at the 20th Annual B. Riley FBR Institutional Investor Conference
2019-05-15,"Acasti Pharma Awarded Notices of Allowance for Additional Composition & Use Patents in Mexico, Chile and Israel"
2019-05-10,Acasti Settles Claims with Former Chief Executive Officer
2019-04-24,Acasti Pharma CEO to Present at the ThinkEquity Conference on May 2nd in New York City
2019-04-15,Acasti Pharma Announces TRILOGY 1 Trial Has Achieved 100% Patient Randomization in Patients with Severe Hypertriglyceridemia
2019-04-01,Acasti Pharma Announces Publication of CaPre Bioavailability Study in Leading Peer-Reviewed Journal
2019-03-26,Acasti Pharma to Present at the 2019 Spring Investor Summit in New York City on April 2nd
2019-03-13,Acasti Pharma to Present at the Oppenheimer 29th Annual Healthcare Conference on March 19th
2019-02-21,Acasti Pharma Recognized in TSX Venture Exchanges 2019 Venture 50
2019-02-14,Acasti: Fiscal 3Q Earnings Snapshot
2019-02-14,Acasti Pharma Provides Business Update for the Third Quarter of Fiscal 2019
2019-02-08,Acasti Pharma Schedules Third Quarter Fiscal 2019 Conference Call
2019-01-09,4 Healthcare Stocks Looking To Set January Highs
2019-01-09,Acasti Pharma Awarded Broad Composition-of-Matter and Method of Use Patents by the European Patent Office
2018-12-31,"Acasti Pharma Announces TRILOGY Phase 3 Trials of CaPre® in Patients with Severe Hypertriglyceridemia Has Now Exceeded 65% Randomization, and More Than 100 Patients (>20%) Have Completed Their 6 Month Treatment Plan"
2018-12-28,Generic Industry on Path to Recovery: 3 Hot Picks for 2019
2018-12-20,Acasti Pharma Achieves Planned Enrollment Targets for TRILOGY Phase 3 Trials of CaPre® in Patients with Severe Hypertriglyceridemia
2018-11-27,Acasti Pharma to Present at the 11th Annual LD Micro Main Event
2018-11-14,Acasti: Fiscal 2Q Earnings Snapshot
2018-11-14,Acasti Pharma Provides Business Update for Second Quarter of Fiscal 2019
2018-11-07,Acasti Pharma Schedules Second Quarter Fiscal 2019 Conference Call
2018-10-23,Acasti Pharma Announces Closing of C$27.6 Million Underwritten Public Offering of Common Shares Including the Exercise of the Over-Allotment Option
2018-10-11,Acasti Pharma Announces Closing of $19.1 Million Underwritten Public Offering of Common Shares
2018-10-10,"Acasti Pharma Looks Toward Phase III for CaPre with Recent Financing, Analysts Review"
